Citigroup’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-231,508
Closed -$24.7M 6522
2025
Q3
$24.7M Buy
231,508
+226,624
+4,640% +$23.7M 0.02% 951
2025
Q2
$462K Buy
4,884
+3,217
+193% +$238K ﹤0.01% 3672
2025
Q1
$106K Buy
1,667
+201
+14% +$12K ﹤0.01% 4573
2024
Q4
$68.1K Buy
1,466
+185
+14% +$6.95K ﹤0.01% 4995
2024
Q3
$36.9K Sell
1,281
-196
-13% -$4.82K ﹤0.01% 5082
2024
Q2
$21.4K Buy
1,477
+1,230
+498% +$18K ﹤0.01% 4982
2024
Q1
$3.97K Sell
247
-961
-80% -$16.6K ﹤0.01% 5339
2023
Q4
$24K Buy
1,208
+376
+45% +$5.55K ﹤0.01% 4912
2023
Q3
$13.6K Sell
832
-298
-26% -$5.74K ﹤0.01% 4484
2023
Q2
$23.9K Buy
1,130
+407
+56% +$8.68K ﹤0.01% 4917
2023
Q1
$14.5K Sell
723
-57
-7% -$1.23K ﹤0.01% 4611
2022
Q4
$20.4K Buy
+780
New +$10.4K ﹤0.01% 4580
2022
Q2
Sell
-369,008
Closed -$1.84M 6713
2022
Q1
$1.84M Buy
+369,008
New +$2.15M ﹤0.01% 2431
2021
Q4
Sell
-495,446
Closed -$2.71M 6120
2021
Q3
$2.71M Buy
+495,446
New +$2.88M ﹤0.01% 2298

Other funds holding VRNA